Dose-Related Efficacy of Aspirin After Coronary Surgery in Patients With PlA2 Polymorphism (NCT00262275)

Annals of Thoracic Surgery

Volumn 83, Issue 1, 2007, Pages 134-138

  Lim, Eric ^a   Carballo, Sebastian ^b   Cornelissen, Jacqueline ^a   Ali, Ziad A ^b   Grignani, Robert ^b   Bellm, Sarah ^a   Large, Stephen ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; CLOPIDOGREL; COLLAGEN; CYCLOOXYGENASE 1; DNA; GLYCOPROTEIN IIIA; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY ARTERY THROMBOSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

AGED; ASPIRIN; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC;

EID: 33845491498     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.08.002     Document Type: Article

References (11)

1. Undas A., Brummel K., Musial J., Mann K.G., and Szczeklik A. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104 (2001) 2666-2672
2. Feng D., Lindpaintner K., Larson M.G., et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19 (1999) 1142-1147
3. Lim E., Cornelissen J., Routledge T., et al. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 128 (2004) 432-435
4. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 164 (1962) 927-929
5. Altman D.G., and Bland J.M. Interaction revisited: the difference between two estimates. Br Med J 326 (2003) 219
6. O'Donnell C.J., Larson M.G., Feng D., et al. Genetic and environmental contributions to platelet aggregation: the Framingham Heart Study. Circulation 103 (2001) 3051-3056
7. Weiss E.J., Bray P.F., Tayback M., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334 (1996) 1090-1094
8. Ridker P.M., Hennekens C.H., Schmitz C., Stampfer M.J., and Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349 (1997) 385-388
9. Kritzik M., Savage B., Nugent D.J., Santoso S., Ruggeri Z.M., and Kunicki T.J. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles that are associated with differences in platelet alpha 2beta 1 density. Blood 92 (1998) 2382-2388
10. Kunicki T.J., Kritzik M., Annis D.S., and Nugent D.J. Hereditary variation in platelet integrin alpha 2beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89 (1997) 1939-1943
11. Halushka M.K., Walker L.P., and Halushka P.V. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 73 (2003) 122-130